Browse > Article
http://dx.doi.org/10.5487/TR.2009.25.1.001

Basic Principles of the Validation for Good Laboratory Practice Institutes  

Cho, Kyu-Hyuk (Division of Inhalation Toxicology, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology)
Kim, Jin-Sung (Department of Non-clinical Studies, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology)
Jeon, Man-Soo (Korea GMP Academy Co., Ltd.)
Lee, Kyu-Hong (Division of Inhalation Toxicology, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology)
Chung, Moon-Koo (Department of Non-clinical Studies, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology)
Song, Chang-Woo (Division of Inhalation Toxicology, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology)
Publication Information
Toxicological Research / v.25, no.1, 2009 , pp. 1-8 More about this Journal
Abstract
Validation specifies and coordinates all relevant activities to ensure compliance with good laboratory practices (GLP) according to suitable international standards. This includes validation activities of past, present and future for the best possible actions to ensure the integrity of non-clinical laboratory data. Recently, validation has become increasingly important, not only in good manufacturing practice (GMP) institutions but also in GLP facilities. In accordance with the guideline for GLP regulations, all equipments used to generate, measure, or assess data should undergo validation to ensure that this equipment is of appropriate design and capacity and that it will consistently function as intended. Therefore, the implantation of validation processes is considered to be an essential step in a global institution. This review describes the procedures and documentations required for validation of GLP. It introduces basic elements such as the validation master plan, risk assessment, gap analysis, design qualification, installation qualification, operational qualification, performance qualification, calibration, traceability, and revalidation.
Keywords
Good laboratory practice; Validation; Qualification; Calibration;
Citations & Related Records
연도 인용수 순위
  • Reference
1 EPA (1989), 40 CFR Part 160, Good Laboratory Practice Standards
2 EU (2003), Guide to Good Manufacturing Practice Annex 15, Qualification and Validation
3 Haider, S.I. (2002b), Pharmaceutical Master Validation Plan, The Ultimate Guide to FDA, GMP, and GLP Compliance. St. Lucie Press, pp. 1-36
4 Huber, L. (2005), Compliance Requirements for Equipment and Instrumentation in GLP Studies in Gap Analysis, Risk Assessment, & Master Validation Plan, 21st SQA Annul Meeting Preconference Training, Florida, USA
5 KFDA (2008), Principle of Validation for Drug and Pharmaceutical Regulation for Nonclinical Laboratory Studies (Notification No. 2008-5) issued by Korea Food and Drug Administration
6 KFDA (2008), Interpretation for Good Laboratory Practice. pp.26-50
7 Korea Pharmaceutical Technique Association (2000), Pharmaceutical Manufacture and Validation. pp. 15-53
8 OECD (1997), OECD Principles of Good Laboratories Practice
9 WHO (1996), A WHO Guide to Good Manufacturing Practice (GMP) Requirements, Part 2: Validation
10 Yu, I.J., Chung, Y.H., Maeng, S.H., Song, K.S., Lee, Y.M., Chung, H.K., Kim, H.J., Park, J.I., Lee, S.K., Lee, Y.H. and Chang, J.S. (1999), History of Korean GLPs and activities and perspectives of the Korean Society of GLP, Quality Assurance, 7, 57-62   DOI
11 Weinberg, S. (2007), Good Laboratory Practice Regulation, Fourth Edition, Informa Healthcare Press, pp. 60-229
12 Yoshihito, O. (1985), Good laboratory practice - principles and present status in Japan, Korean J. of Toxicology, 1, 31-41   과학기술학회마을
13 Yu, I.J., Maeng, S.H., Lee, J.Y., Lee, Y.M. and Chung, H.K.(2000), Designation of a GLP facility by the Korean ministry of environment GLP authority: The case of the center for occupational toxicology, Quality Assurance, 8, 11-17   DOI
14 Haider, S.I. (2002a), Validation Standard Operating Procedures, A Step-by-Step Guide for Achieving Compliance in the Pharmaceutical, Medical Device, and Biotech Industries, St. Lucie Press, pp. 3-150
15 Leveson, N. and Turner, C.S. (1993), An investigation of the therac-25 accidents, IEEE Computer, 26, 18-41   DOI
16 www.labcompliance.com
17 LabComplience (2004), Validation Master Plan, for Equipment, Computer Systems, Networked Systems and Spreadsheet Applications, Ver. 2.07, pp. 1-40
18 Huber, L. (1999), Validation and Qualification in Analytical Laboratories, Interpharm Press, pp. 27-106
19 OECD (1999), Revised Consensus Document, The Study Director in GLP Studies, Environment Monograph No. 99(24)
20 US FDA (2003), 21 CFR Part 58, Good Laboratory Practice for Nonclinical Laboratory Studies
21 Brockmeyer, P. (2006), 29th Biological GMP and validation Education, Process Validation Fundamentals, pp. 21-28, Risk Based Process Validation Review & Risk Assessment Example, pp. 5-9
22 Bedson, P. and Sargent, M. (1996), The development and application of guidance on equipment qualification of analytical instruments, Accred. Qual. Assur, 1, 265-274   DOI   ScienceOn
23 KFDA (2005), Good Laboratory Practice Regulation for Nonclinical Laboratory Studies (Notification No. 2005-79) issued by Korea Food and Drug Administration
24 International Standard ISO/IEC 17025:2005 (2006), General requirements for the competence of testing and calibration laboratories
25 KFDA (2007), Good Clinical Practice Regulation for Nonclinical Laboratory Studies (Notification No. 2007-34) issued by Korea Food and Drug Administration
26 Gibson, W. and Powell-Evans, K. (1998), Validation Fundamentals, How to, What to, When to Validate, Interpharm/ CRC, pp. 1-205
27 Yu, J.H. (2004), Risk Assessment for Validation, IVS,www.validation.co.kr
28 US FDA (1987), Guideline on General Principles of Process Validation
29 Matthews, B.R. (2002), The Devonport incident, the Clothier Report, and related matters - 30 years on, PDA J. Pharm. Sci. Technol., 56, 137-149
30 Bridges, D. (2005), Compliance requirements for equipment and instrumentation in GLP studies, Society of quality assurance first global QA conference 21st SQA annual meeting preconference training, Florida. USA. pp. 1-17
31 MIHWAF (2008), The Pharmaceutical Affairs Act, Annex 2: Good Manufacturing Practice and Quality Standards